-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lipella Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2022 to Q2 2024.
- Lipella Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$952K, a 39.6% increase year-over-year.
- Lipella Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.26M, a 14.1% decline year-over-year.
- Lipella Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$4.75M, a 83.3% decline from 2022.
- Lipella Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$2.59M, a 35.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)